circulating cell-free DNA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

67,786 results for “circulating cell-free DNA”

Trials

View all 45505 →

Not yet recruiting

OPTImisation and Standardization of CIRCulating Cell-free DNA Ex-traction Protocols in a Diagnostic Setting

10 participants · First posted Mar 11, 2025

Not yet recruiting

Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study

15 participants · First posted Mar 18, 2026

Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.

200 participants · First posted Jan 14, 2014

Drugs

View all 5524 →

cell-free stem cell-derived extract formulation

Cell-free Stem cell-derived Extract(General Therapeutics)

Investigational

Minnelide free acid

C₂₁H₂₇O₁₀P

Organizations

View all 233 →

DNA International Hospital

Vietnam

Free University of Brussels

Ginkgo Bioworks

United States

News

View all 16524 →

Singlera Genomics Partners with Pure Medical to Expand DNA Methylation Cancer Detection Technology Across Europe

Tagomics launches LiquiPath, a first-in-class cfDNA blood test for multi-organ drug safety monitoring

YD Bio Partner EG Biomed Secures CAP Accreditation for U.S. Laboratory, Strengthening Cancer Diagnostics Capabilities

Page 1 of 6779